奥星生命科技(06118.HK)中期业绩扭亏为盈至416.9万元
格隆汇8月26日丨奥星生命科技(06118.HK)公布,截至2019年6月30日止6个月,公司实现收入人民币4.78亿元(单位下同),同比增长45.46%;毛利1.27亿元,同比增长47.76%;公司拥有人应占溢利416.9万元,同期录得亏损372.5万元,实现扭亏为盈,每股基本盈利0.01元。
于回顾期内,公司录得订单及收入较去年同期显著增长约37.6%及45.5%。受益于约3年前推出的重组决定与努力,公司目前逐渐受益于该项组织重组的积极成果。通过提升集团各业务板块的能力及知识进行转型,需要在此期间进一步招聘与聘用世界级人才和顾问,这可能会影响公司的部分利润率;然而,预计该等举措将带来长期业绩成果。凭藉公司的企业策略及对公司愿景与策略的承诺,集团仍积极投资于人力资源,拓展地域及提升产品与应用解决方案的能力,旨在为股东带来更满意的业务成果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.